Medi Assist Ser. Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Published 25 Aug 2026 | Insurance | Market Cap: ₹2.7K Cr
Core business (group and retail segments) expected to grow at or faster than market rates, maintaining steady growth. Medi Assist expects to grow at par or faster than the market in group and retail segments, maintaining mid-teen growth trajectory.
From Medi Assist Ser.'s Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Price
₹355
Market Cap
₹2.7K Cr
P/E Ratio
27.3
Revenue Rank
Margin Rank
How does Medi Assist Ser. rank in Insurance?
Compare Medi Assist Ser. against every Insurance company this quarter on revenue, margins and earnings-call signals.
Medi Assist Ser. — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹242 Cr, net profit ₹54 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 2- →Core business (group and retail segments) expected to grow at or faster than market rates, maintaining steady growth.
- →Government business remains a meaningful and margin-accretive contributor, with performance-driven schemes across 16 states.
- →Technology SaaS business exhibiting strong growth (55.5% YoY in Q1 FY27) and anticipated to be a significant revenue and margin contributor over time.
- →International business poised for accelerated growth with contracts in Thailand and expansion opportunities; expected higher yields and margins than domestic business.
- →Same-store growth for group business steady around 7%-8%; retention rates targeted to improve from current ~90% back to historical 93%-94%.
- →New business additions continue seasonally, with overall revenue benefiting from portfolio rationalization and integration efficiencies.
- →Technology investments expected to drive operational leverage and margin improvement over medium term.
- →Management targets mid-teen percentage growth for overall business, leveraging technology and international expansion.
📈 Profitability & Margins
Rank 3- →Medi Assist expects to grow at par or faster than the market in group and retail segments, maintaining mid-teen growth trajectory.
- →Government business will remain a meaningful revenue and size contributor, though more opportunistic.
- →Technology segment shows strong growth potential, already demonstrating significant revenue increases (55.5% YoY in Q1 FY27); expected to drive faster future growth and margin improvements.
- →International business holds high-growth potential, with technology contracts active and plans to scale globally, particularly in Thailand.
- →Margin improvement target is to return to historical EBITDA margins (~23%) by the end of FY27 post-Paramount integration.
- →Operating leverage anticipated from technology investments as they scale.
- →FY27 expected to deliver record profits supported by operational efficiencies, margin expansion, and growth across all lines of business.
🏗️ Capital Expenditure Plans
Yes- →The transcript does not explicitly mention any current or future capital expenditure (capex) plans.
- →Strategic investments are focused on technology and international business expansion.
- →Investments are being funded from operating cash flows.
- →The company is investing in:
- → - Technology business to build pure execution capabilities and contribute to growth and margins.
- → - International business, including contracts in Thailand and expanding networks globally.
- →Technology plays a pivotal role in improving operating efficiency, scaling the TPA business, and enabling new revenue streams.
- →Integration of acquired businesses (Paramount) is ongoing with a focus on migrating claims to the Medi Assist technology stack by Q2 FY27.
- →The company aims for technology and international segments to become meaningful contributors to growth and EBITDA margins over time.
💰 Fundraising & Capital Structure
No information- →There is no mention of any current or future fundraising through debt or equity in the transcript.
- →The company continues to remain debt-free with a free cash position of INR 245.5 crores as of Q1 FY27.
- →Growth and investments in technology and international business are being funded from the company’s own operating cash flows.
- →The company focuses on improving operational efficiency, reducing receivables, and deploying technology to drive growth and margins.
- →No indication or plan for raising external capital through debt or equity was discussed during the call.
📋 Order Book & Pipeline
No informationKey Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Continue your research
What Medi Assist Healthcare Services Ltd's management said in earlier quarters
Others in Insurance this season
- Niva Bupa Health (Q1 FY27)
Group portfolio growth remains selective, focusing on profitable segments like SMEs growing over 50% (Page 6). Key concall takeaways from Niva Bupa Health's Q1…
- HDFC Life Insur. (Q1 FY27)
Agency channel growing strongly at around 21%, driven by new agents and branch expansion. Key concall takeaways from HDFC Life Insur.'s Q1 FY27 earnings call…
- Go Digit General (Q1 FY27)
Motor business is flat overall; strong growth in 2-wheeler segment (around 21-23%), but decline in commercial vehicles (-27%). Key concall takeaways from Go…
- ICICI Pru Life (Q1 FY27)
Partnership distribution channel continues to be a key growth driver with a near 20% CAGR over the past five years; growth is broad-based across 1,000+…
Frequently Asked Questions
What were Medi Assist Ser. Q1 FY27 results?
Core business (group and retail segments) expected to grow at or faster than market rates, maintaining steady growth. Medi Assist expects to grow at par or faster than the market in group and retail segments, maintaining mid-teen growth trajectory.
What is Medi Assist Ser. share price analysis?
Medi Assist Ser. currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 27.3 with a market cap of ₹2,695 Cr. Investors should review the full earnings analysis for detailed insights.
Is Medi Assist Ser. planning capital expenditure?
The transcript does not explicitly mention any current or future capital expenditure (capex) plans.
Keep Medi Assist Ser. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.